Evidence map›Paper›PMID 38153143›Full record

ArticleNucleic acids research2024

BG4 antibody can recognize telomeric G-quadruplexes harboring destabilizing base modifications and lesions.

Samuel A Johnson, Tapas Paul, Samantha L Sanford, Brittani L Schnable, Ariana C Detwiler, Sanjana A Thosar, Bennett Van Houten, Sua Myong, Patricia L Opresko

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Imaging nucleic acids in biofilms.Essays in biochemistry · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Light-Activated Molecules Targeting G-Quadruplex Nucleic Acids.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Samuel A JohnsonDepartment of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, USA.
Tapas PaulDepartment of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.
Samantha L SanfordDepartment of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, USA.
Brittani L SchnableUPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.
Ariana C DetwilerDepartment of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, USA.
Sanjana A ThosarDepartment of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, USA.
Bennett Van HoutenUPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.ORCID 0000-0002-4009-2478
Sua MyongDepartment of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.ORCID 0000-0001-9098-3423
Patricia L OpreskoDepartment of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, USA.ORCID 0000-0002-6470-2189

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
Supplement to Promote DiversityR35ES030396 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Patricia L Opresko · 2019 to 2026
$7.5M
Watching cooperative interactions between base and nucleotide excision repair proteinsR35ES031638 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bennett Van Houten · 2020 to 2026
$6.2M
Roles of Telomeric Oxidative DNA Lesions in Telomere Length RegulationR01CA207342 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sua Myong, Patricia L Opresko · 2017 to 2026
$3.7M
Mechanisms of Telomeric DNA Loss and RepairR01ES015052 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OPRESKO, PATRICIA L · 2006 to 2010
$2.4M
Investigating how chemotherapeutic thiopurines inhibit telomerase elongation of telomeresF32CA275287 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SANFORD, SAMANTHA · 2023 to 2025
$226k
NCI NIH HHS F32 CA275287NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA207342NIEHS NIH HHS R01 ES015052NIEHS NIH HHS R35 ES030396NIEHS NIH HHS R35 ES031638NIH HHS R35ES030396
6 · The paper itself

Abstract

BG4 is a single-chain variable fragment antibody shown to bind various G-quadruplex (GQ) topologies with high affinity and specificity, and to detect GQ in cells, including GQ structures formed within telomeric TTAGGG repeats. Here, we used ELISA and single-molecule pull-down (SiMPull) detection to test how various lengths and GQ destabilizing base modifications in telomeric DNA constructs alter BG4 binding. We observed high-affinity BG4 binding to telomeric GQ independent of telomere length, although three telomeric repeat constructs that cannot form stable intramolecular GQ showed reduced affinity. A single guanine substitution with 8-aza-7-deaza-G, T, A, or C reduced affinity to varying degrees depending on the location and base type, whereas two G substitutions in the telomeric construct dramatically reduced or abolished binding. Substitution with damaged bases 8-oxoguanine and O6-methylguanine failed to prevent BG4 binding although affinity was reduced depending on lesion location. SiMPull combined with FRET revealed that BG4 binding promotes folding of telomeric GQ harboring a G to T substitution or 8-oxoguanine. Atomic force microscopy revealed that BG4 binds telomeric GQ with a 1:1 stoichiometry. Collectively, our data suggest that BG4 can recognize partially folded telomeric GQ structures and promote telomeric GQ stability.

Indexed as

G-QuadruplexesAntibodiesDNATelomereAntibodiesDNA

Identifiers

PMID38153143
PMCPMC10939409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.